Diagnostics
A finger-prick test is being trialled in the UK, US and Canada to see if it can help diagnose Alzheimer’s disease in people aged over 60. The study involves 1,000 volunteers and will look for biomarkers linked to Alzheimer’s by analysing blood from a simple finger-prick. Biomarkers are measurable signs in the body, and researchers [...]
Women’s health exits topped US$100bn in acquisitions and IPOs from 2000 to 2025, according to new research. Released at the JPMorgan Healthcare Conference in San Francisco, the research logs 276 exits and 27 billion-dollar deals, including US$27bn in transactions in 2025 alone, the biggest year on record for the category. The report, Follow the Exits: [...]
Bath-based InnotiveDx has won a £1m grant to advance its rapid UTI test, delivering results in under 60 minutes. The funding from PACE (Pathways to Antimicrobial Clinical Efficacy) will support development of the InnotiveUTI test, which provides bacterial identification and antimicrobial susceptibility testing (checking which antibiotics will work) at the point of care. This tackles [...]
The NHS’s first prostate cancer screening programme could receive approval this week from the government’s National Screening Committee. The National Screening Committee (NSC) meets on Thursday to decide whether to introduce wider screening to detect disease earlier. Any rollout would likely focus on those at highest risk, including people with a family history or specific [...]
New pinprick blood tests could detect early signs of disease more than 10 years before symptoms appear, following analysis of samples from 500,000 people. The tests are being developed after researchers completed measurements of nearly 250 different proteins, sugars, fats and other compounds in blood collected from half a million volunteers. These molecular profiles provide [...]
The NHS England Medium-Term Planning Framework 2026–2029 sets out a vision for transforming how care is delivered. With targets like treating 92 per cent of patients within 18 weeks, reducing diagnostic waits to under six weeks for 99 per cent of patients, and treating 85 per cent of cancer patients within 62 days, the Framework [...]
Prostate cancer screening could reduce deaths by 13 per cent, research has revealed, prompting UK experts to assess whether to introduce a national screening programme. Cancer screening specialists are reviewing the evidence, with a decision expected before the end of the year on whether routine prostate testing should be introduced across the UK. A new [...]
Ergéa UK was proud to join clinical leaders from Somerset NHS Foundation Trust and Actiform at the ground-breaking ceremony for the new Bridgwater Community Diagnostic Centre - a milestone moment in our long-term partnership with the Trust. The project recently received conditional planning approval, paving the way for the new facility to welcome its first [...]
Men checked for prostate cancer on the NHS could soon get same-day results, with artificial intelligence processing MRI scans in seconds under new pilot schemes. Patients assessed by the AI as high risk would be sent straight to a radiologist for an on-the-spot biopsy – a tissue test to confirm whether cancer is present. Results [...]
Low oxygen levels can alter immune cell genes, weakening the body’s ability to fight infection even after oxygen levels return to normal, new research has revealed. Scientists found that oxygen deprivation – known as hypoxia – changes the genetic material of neutrophils, white blood cells that form one of the body’s first lines of defence [...]
